Upcoming Global Web Symposia
March 20, 2012
11:30 am – 1:00 pm EDT
Lab on a Chip Diagnostics Trailer
Symposium Length: 1 hour + 30 min Q&A
Symposium Course Description: Lab-on-a-chip (LOC) devices have a tremendous potential for improving the health of the population by providing immediate diagnosis. This potential has largely been unfulfilled, despite many promising academic studies. This course will go over state-of-the-art developments in the academic arena, as well as past challenges faced by companies in commercializing promising technologies. In addition, the course will discuss the development of diagnostics for global health, which presents unique and challenging design criteria. The case study presented will be the instructor’s personal experience in helping to develop tests for prostate cancer and infectious diseases.
Learning Objective Bullet Points:
Who Should Attend:
Technology Development Manager
Samuel Sia, Ph.D., Associate Professor, Biomedical Engineering, Columbia University
He obtained his B.S. in Biochemistry at the University of Alberta, Ph.D. in Biophysics at Harvard University, and postdoctoral fellowship in Chemistry at Harvard University. He was a Howard Hughes Medical Institute Predoctoral Fellow, National Science and Engineering Council of Canada Predoctoral Fellow, and Canadian Institute of Health Postdoctoral Fellow. Since 2005, he has been a faculty member of Columbia University's Biomedical Engineering department. His lab's work has been supported by the NIH (NHLBI and NINR), NSF, Wallace H. Coulter Foundation, American Heart Association, and World Health Organization. He has been named one of the world's top young innovators by MIT Technology Review, and one of 10 innovators in human health and sustainability by NASA. His research has been covered by NPR, Washington Post, CBS, NBC, BBC, CBC, Voice of America, and Agence France Presse. He is a founder of Claros Diagnostics, a venture capital-backed company that is developing novel point-of-care diagnostics products; the company's first microfluidics product for monitoring prostate cancer growth received European Union regulatory approval in 2010.
250 First Avenue Suite 300Needham, MA 02494P: 781.972.5400F: 781.972.5425E: firstname.lastname@example.org
biological therapeutic productsbiomarkers & diagnosticsbiopharma strategybioprocess & manufacturingchemistryclinical trials & translational medicinedrug & device safety
drug discovery & developmentdrug targetsgenomicshealthcareit & informaticstechnology & tools for life sciencetherapeutic indications
conferencesreportsbarnett educational servicesconsultingpublications & eNewslettersprofessional services
executive teamtestimonialschi timelinemailing listcareers